Specifically, CtBPs are involved in modulating genes implicated in tumor suppression and cell cycle progression, such as E-cadherin (also known as cadherin 1, CDH1), cyclin-dependent kinase inhibitor 1 A (CDKN1A), and CDKN2A [18]. The gene discussed is CDH1; the disease is neoplasm.